Weight lifting may reduce physical function deterioration among breast cancer survivors
the ONA take:
According to findings published online early in the Journal of Clinical Oncology, researchers from the Perelman School of Medicine at University of Pennsylvania in Philadelphia have found that slowly progressive weight lifting compared with standard of care reduced the incidence of physical function deterioration among breast cancer survivors.
For the single-blind, 12-month, controlled trial, researchers enrolled 295 survivors of nonmetastatic breast cancer and randomly assigned them to twice-per-week slowly progressive weight lifting or standard of care.
Results showed that 16.3% of those in the control group experienced incident physical function deterioration after 12 months compared with 8.1% in the weight lifting group (P = 0.04). Researchers did not observe any serious or unexpected adverse events related to weight lifting.
The researchers note that future studies should compare efficacy of weight lifting with other exercises, such as brisk walking, in order to develop a confirmatory study aimed at identifying the best approach to preserving physical function among breast cancer survivors.
Breast cancer survivors may experience physical function deterioration, which may lead to bone fracture, disability, injurious falls, and premature death.
Slowly progressive weight lifting reduced the incidence of physical function deterioration among breast cancer survivors.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|